Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Targeted therapies associated with increased risk for and incidence of...

Dr James Martin - Cleveland Clinic, Cleveland, USA

Targeted therapies associated with increased risk for and incidence of thrombosis in the treatment of breast cancer ( Dr James Martin - Cleveland Clinic, Cleveland, USA )

The use of IORT at L'Hospitalet de Llobregat

Dr Evelyn Martínez Pérez - Catalan Institute of Oncology, Barcelona, Spain

The use of IORT at L'Hospitalet de Llobregat ( Dr Evelyn Martínez Pérez - Catalan Institute of Oncology, Barcelona, Spain )

Understanding intraoperative radiation therapy for early stage breast cancer

Dr Jana Fox - Montefiore Medical Center, New York,USA

Understanding intraoperative radiation therapy for early stage breast cancer ( Dr Jana Fox - Montefiore Medical Center, New York,USA )

The use of IORT at Montefiore Medical Center

Dr Sheldon Feldman - Montefiore Einstein Comprehensive Cancer Center, New York...

The use of IORT at Montefiore Medical Center ( Dr Sheldon Feldman - Montefiore Einstein Comprehensive Cancer Center, New York, USA )

Patients with early-stage, HR+/HER2-negative BC may benefit from adjuvant T-AC...

Dr Nan Chen - The University of Chicago, Chicago, USA

Patients with early-stage, HR+/HER2-negative BC may benefit from adjuvant T-AC therapy more than from TC ( Dr Nan Chen - The University of Chicago, Chicago, USA )

Postmastectomy radiotherapy in 'intermediate-risk' breast cancer does not...

Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK

Postmastectomy radiotherapy in 'intermediate-risk' breast cancer does not impact overall survival ( Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK )

HER3-DXd demonstrates similar efficacy compared to multi-agent chemotherapy in...

Dr Mafalda Oliveira - Vall d'Hebron University Hospital and Vall d'Hebron...

HER3-DXd demonstrates similar efficacy compared to multi-agent chemotherapy in high-risk HR-positive/HER2-negative eBC ( Dr Mafalda Oliveira - Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )

Olaparib after chemotherapy continues to meaningfully improveme efficacy in...

Dr Judy Garber - Dana-Farber Cancer Institute, Boston, USA

Olaparib after chemotherapy continues to meaningfully improveme efficacy in gBRCApv and high-risk, HER2-negative primary BC ( Dr Judy Garber - Dana-Farber Cancer Institute, Boston, USA )

Immediate breast surgery versus deferral of surgery in women aged 70+ years...

Prof Robert Hills - University of Oxford, Oxford, United Kingdom

Immediate breast surgery versus deferral of surgery in women aged 70+ years with operable breast cancer ( Prof Robert Hills - University of Oxford, Oxford, United Kingdom )

Breast conserving surgery and IORT can manage locally recurrent breast cancer

Dr Fabiana Gregucci - Weill Cornell Medicine, New York, USA

Breast conserving surgery and IORT can manage locally recurrent breast cancer ( Dr Fabiana Gregucci - Weill Cornell Medicine, New York, USA )

Addressing Breast Cancer Disparities in Africa

Dr Paul Chilwesa - Population Health & Health Systems Strengthening Roche...

Addressing Breast Cancer Disparities in Africa ( Dr Paul Chilwesa - Population Health & Health Systems Strengthening Roche, Basel, Switzerland )

Recommendations and guidance for people living with and beyond breast cancer...

Dr Helen Croker - World Cancer Research Fund International, London, UK

Recommendations and guidance for people living with and beyond breast cancer and colorectal cancer ( Dr Helen Croker - World Cancer Research Fund International, London, UK )

More from ecancer